Skip navigation
Explore
Sciety application settings
Home
Groups
Lists
Newsletter
About
Log In
Sign Up
Carfilzomib shows therapeutic potential for reduction of liver fibrosis by targeting hepatic stellate cell activation
Ayana Fujiwara
Keisuke Takemura
Anna Tanaka
Misaki Matsumoto
Masato Katsuyama
Takeshi Okanoue
Kanji Yamaguchi
Yoshito Itoh
Kazumi Iwata
Kikuko Amagase
Atsushi Umemura
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41598-024-70296-8
Aug 20, 2024
Version published to 10.21203/rs.3.rs-4453616/v1 on Research Square
Jun 11, 2024
Related articles
Bile acid-mediated activation of hepatic stellate cells and myeloid cell leukemia- 1 triggers hepatocarcinogenesis
This article has 7 authors:
Yuri Cho
Minjong Lee
Min Ji Park
Narae Jung
Hyunjae Shin
Bo Hyun Kim
Joong-Won Park
Hepatoprotective effect of L-carnitine is achieved via activating Nrf2 and targeting TLR4 signaling pathways in Thioacetamide –induced liver fibrosis in rats
This article has 4 authors:
Mostafa Abbas Shalaby
Amer Ramadan
Sahar S. Abd El-Rahman
Hany M. Fayed
Two types of regeneration mechanism in acute liver injury
This article has 9 authors:
Tomomi Aoyagi
Takeshi Goya
Koji Imoto
Yuki Azuma
Tomonobu Hioki
Motoyuki Kohjima
Masatake Tanaka
Yoshinao Oda
Yoshihiro Ogawa
Site navigation links
Home
Groups
Lists
Newsletter
About
Log In
Sign Up